Abstract: The present disclosure relates to a system, apparatus, or method for testing of pet products and their resulting impact on pets. Certain embodiments include collecting, at a server, data related to one or more teeth of a pet, where the data results from the testing of the pet product. Certain embodiments also include mapping, by the server, the data to a heatmap representation of the one or more teeth of the pet. The heatmap representation illustrates a statistical analysis of the data. In addition, certain embodiments determine based on the statistical analysis of the data illustrated in the heatmap representation an impact of the pet product on the one or more teeth of the pet.

Abstract: The present disclosure relates to a system, apparatus, or method for testing of pet products and their resulting impact on pets. Certain embodiments include collecting, at a server, data related to one or more teeth of a pet, where the data results from the testing of the pet product. Certain embodiments also include mapping, by the server, the data to a heatmap representation of the one or more teeth of the pet. The heatmap representation illustrates a statistical analysis of the data. In addition, certain embodiments determine based on the statistical analysis of the data illustrated in the heatmap representation an impact of the pet product on the one or more teeth of the pet.

Abstract: The present disclosure relates to a system, apparatus, or method for testing of pet products and their resulting impact on pets. Certain embodiments include collecting, at a server, data related to one or more teeth of a pet, where the data results from the testing of the pet product. Certain embodiments also include mapping, by the server, the data to a heatmap representation of the one or more teeth of the pet. The heatmap representation illustrates a statistical analysis of the data. In addition, certain embodiments determine based on the statistical analysis of the data illustrated in the heatmap representation an impact of the pet product on the one or more teeth of the pet.

Abstract: The invention relates to methods of treating protein degradation disorders, such cellular proliferative disorders (e.g., cancer) and protein deposition disorders (e.g., neurodegenerative disorders). The invention provides methods and pharmaceutical compositions for treating these diseases using aggresome inhibitors or combinations of aggresome inhibitors and proteasome inhibitors. The invention further relates to methods and pharmaceutical compositions for treating multiple myeloma. New HDAC/TDAC inhibitors and aggresome inhibitors are also provided as well as synthetic methodologies for preparing these compounds.

Abstract: The invention relates to methods of treating protein degradation disorders, such cellular proliferative disorders (e.g., cancer) and protein deposition disorders (e.g., neurodegenerative disorders). The invention provides methods and pharmaceutical compositions for treating these diseases using aggresome inhibitors or combinations of aggresome inhibitors and proteasome inhibitors. The invention further relates to methods and pharmaceutical compositions for treating multiple myeloma. New HDAC/TDAC inhibitors and aggresome inhibitors are also provided as well as synthetic methodologies for preparing these compounds.

Abstract: The invention relates to methods of treating protein degradation disorders, such cellular proliferative disorders (e.g., cancer) and protein deposition disorders (e.g., neurodegenerative disorders). The invention provides methods and pharmaceutical compositions for treating these diseases using aggresome inhibitors or combinations of aggresome inhibitors and proteasome inhibitors. The invention further relates to methods and pharmaceutical compositions for treating multiple myeloma. New HDAC/TDAC inhibitors and aggresome inhibitors are also provided as well as synthetic methodologies for preparing these compounds.

Abstract: The invention relates to methods of treating protein degradation disorders, such cellular proliferative disorders (e.g., cancer) and protein deposition disorders (e.g., neurodegenerative disorders). The invention provides methods and pharmaceutical compositions for treating these diseases using aggresome inhibitors or combinations of aggresome inhibitors and proteasome inhibitors. The invention further relates to methods and pharmaceutical compositions for treating multiple myeloma. New HDAC/TDAC inhibitors and aggresome inhibitors are also provided as well as synthetic methodologies for preparing these compounds.

Abstract: FtsZ, the bacterial analog of tubulin, is a promising new target for developing new antibiotics. It has been shown that polyphenols inhibit the GTPase activity of FtsZ, thereby inhibiting Z-ring formation during mitosis. The present invention provides novel polyphenols compounds, which can be accessed by the synthesis of dichamametin and 2??-hydroxy-5?-benzylisouvarinol-B as described herein. These novel compounds are useful in treating infections, particularly infections caused by gram-positive organisms. Methods of preparing the inventive compounds are also provided. The compounds are prepared by the benzylation of pinocembrin or chrysin core structure. Pharmaceutical compositions and method of using the compounds to treat disease are also provided. These compounds may be screened for antimicrobial activity as well as other biological activities such as anti-neoplastic, anti-inflammatory, immunosuppressive, and cytotoxic activity.

Abstract: The invention relates to methods of treating protein degradation disorders, such cellular proliferative disorders (e.g., cancer) and protein deposition disorders (e.g., neurodegenerative disorders). The invention provides methods and pharmaceutical compositions for treating these diseases using aggresome inhibitors or combinations of aggresome inhibitors and proteasome inhibitors. The invention further relates to methods and pharmaceutical compositions for treating multiple myeloma. New HDAC/TDAC inhibitors and aggresome inhibitors are also provided as well as synthetic methodologies for preparing these compounds.